Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurofibromin 2 | 25 | 2023 | 268 | 5.020 |
Why?
|
Cytoskeletal Proteins | 18 | 2018 | 1325 | 2.130 |
Why?
|
Neurofibromatosis 2 | 13 | 2023 | 387 | 1.810 |
Why?
|
Cytoskeleton | 11 | 2018 | 1178 | 1.330 |
Why?
|
Neurilemmoma | 5 | 2023 | 522 | 0.980 |
Why?
|
Contact Inhibition | 3 | 2015 | 46 | 0.940 |
Why?
|
Morphogenesis | 4 | 2021 | 744 | 0.850 |
Why?
|
Cell Polarity | 4 | 2014 | 636 | 0.780 |
Why?
|
Ephrins | 1 | 2021 | 28 | 0.740 |
Why?
|
Organogenesis | 2 | 2018 | 213 | 0.740 |
Why?
|
Neurofibromatosis 1 | 5 | 2014 | 560 | 0.680 |
Why?
|
Cell Proliferation | 9 | 2018 | 10429 | 0.660 |
Why?
|
Microfilament Proteins | 7 | 2015 | 1130 | 0.650 |
Why?
|
Cell Membrane | 11 | 2018 | 3634 | 0.640 |
Why?
|
Actomyosin | 2 | 2018 | 112 | 0.620 |
Why?
|
Epidermal Growth Factor | 2 | 2018 | 698 | 0.620 |
Why?
|
Pinocytosis | 1 | 2018 | 64 | 0.610 |
Why?
|
Signal Transduction | 18 | 2021 | 23601 | 0.570 |
Why?
|
Cell Communication | 3 | 2018 | 1660 | 0.570 |
Why?
|
Adherens Junctions | 2 | 2010 | 89 | 0.550 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2018 | 307 | 0.530 |
Why?
|
Neurofibromin 1 | 4 | 2012 | 190 | 0.530 |
Why?
|
Genes, Neurofibromatosis 2 | 8 | 2009 | 122 | 0.510 |
Why?
|
Membrane Proteins | 13 | 2015 | 7851 | 0.490 |
Why?
|
Sodium Channels | 6 | 1993 | 334 | 0.460 |
Why?
|
Intestinal Mucosa | 3 | 2012 | 3046 | 0.460 |
Why?
|
Actins | 4 | 2018 | 2056 | 0.450 |
Why?
|
Phosphoproteins | 5 | 2010 | 2446 | 0.440 |
Why?
|
Basement Membrane | 1 | 2014 | 349 | 0.420 |
Why?
|
GTPase-Activating Proteins | 2 | 2014 | 465 | 0.410 |
Why?
|
Cafe-au-Lait Spots | 1 | 2012 | 20 | 0.410 |
Why?
|
Homeostasis | 3 | 2018 | 3336 | 0.400 |
Why?
|
Animals | 58 | 2023 | 168764 | 0.350 |
Why?
|
Epithelial Cells | 4 | 2014 | 3681 | 0.350 |
Why?
|
Integrins | 1 | 2014 | 840 | 0.330 |
Why?
|
Mice | 42 | 2023 | 81819 | 0.320 |
Why?
|
Nervous System Neoplasms | 2 | 2007 | 91 | 0.310 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2018 | 2423 | 0.310 |
Why?
|
Schwann Cells | 4 | 2023 | 195 | 0.310 |
Why?
|
Neurofibroma | 1 | 2009 | 94 | 0.310 |
Why?
|
Transcription Factors | 3 | 2018 | 12131 | 0.290 |
Why?
|
Neoplasms | 9 | 2018 | 22340 | 0.290 |
Why?
|
Epidermis | 1 | 2010 | 538 | 0.290 |
Why?
|
Proteome | 1 | 2018 | 1899 | 0.290 |
Why?
|
Stem Cells | 2 | 2010 | 3540 | 0.270 |
Why?
|
Intercellular Junctions | 2 | 2018 | 198 | 0.260 |
Why?
|
Genes, Tumor Suppressor | 2 | 2023 | 1061 | 0.260 |
Why?
|
Protein Transport | 3 | 2021 | 1939 | 0.250 |
Why?
|
Cell Adhesion | 7 | 2014 | 3089 | 0.250 |
Why?
|
Hepatomegaly | 2 | 2018 | 83 | 0.240 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2012 | 1624 | 0.230 |
Why?
|
Disease Models, Animal | 11 | 2014 | 18293 | 0.230 |
Why?
|
Epithelium | 1 | 2009 | 1599 | 0.230 |
Why?
|
Myotonia Congenita | 3 | 1992 | 16 | 0.220 |
Why?
|
Failure to Thrive | 1 | 2004 | 138 | 0.210 |
Why?
|
Nerve Sheath Neoplasms | 2 | 2004 | 170 | 0.210 |
Why?
|
Neoplasm Metastasis | 3 | 2003 | 4893 | 0.200 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2880 | 0.200 |
Why?
|
Osteosarcoma | 4 | 2008 | 909 | 0.190 |
Why?
|
Gene Silencing | 2 | 2007 | 1505 | 0.190 |
Why?
|
Repressor Proteins | 1 | 2012 | 2968 | 0.190 |
Why?
|
Rhabdomyosarcoma | 1 | 2004 | 354 | 0.180 |
Why?
|
rac GTP-Binding Proteins | 1 | 2001 | 164 | 0.180 |
Why?
|
Neoplasms, Experimental | 4 | 2004 | 1229 | 0.170 |
Why?
|
Neurofibromatoses | 2 | 2014 | 303 | 0.170 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2001 | 134 | 0.170 |
Why?
|
Microvilli | 4 | 2010 | 234 | 0.160 |
Why?
|
Neoplasm Invasiveness | 3 | 2011 | 3602 | 0.160 |
Why?
|
Mechanotransduction, Cellular | 2 | 2015 | 540 | 0.160 |
Why?
|
Mammary Glands, Human | 1 | 2020 | 199 | 0.160 |
Why?
|
Blood Proteins | 2 | 2003 | 1188 | 0.150 |
Why?
|
Paracrine Communication | 1 | 2020 | 277 | 0.150 |
Why?
|
Gene Deletion | 3 | 2018 | 2666 | 0.150 |
Why?
|
Cells, Cultured | 6 | 2020 | 18973 | 0.150 |
Why?
|
Gastrula | 1 | 1997 | 83 | 0.140 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9601 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2003 | 2844 | 0.140 |
Why?
|
Embryonic and Fetal Development | 1 | 1997 | 419 | 0.130 |
Why?
|
Repetitive Sequences, Nucleic Acid | 4 | 1992 | 780 | 0.130 |
Why?
|
Mutation | 11 | 2023 | 30198 | 0.130 |
Why?
|
Liver Neoplasms | 2 | 2010 | 4353 | 0.130 |
Why?
|
Paralyses, Familial Periodic | 2 | 1992 | 13 | 0.130 |
Why?
|
Nonmuscle Myosin Type IIA | 1 | 2015 | 28 | 0.130 |
Why?
|
Skin | 1 | 2009 | 4489 | 0.120 |
Why?
|
Tumor Suppressor Proteins | 1 | 2005 | 2796 | 0.120 |
Why?
|
Cell Adhesion Molecules | 2 | 2012 | 1612 | 0.120 |
Why?
|
Genes, Neurofibromatosis 1 | 2 | 2007 | 76 | 0.120 |
Why?
|
Liver | 1 | 2010 | 7562 | 0.120 |
Why?
|
Mesothelioma | 2 | 2014 | 771 | 0.110 |
Why?
|
Ornithine-Oxo-Acid Transaminase | 3 | 1990 | 49 | 0.110 |
Why?
|
Gyrate Atrophy | 2 | 1990 | 16 | 0.110 |
Why?
|
Chromosomes, Human, Pair 4 | 5 | 1992 | 378 | 0.110 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2014 | 121 | 0.110 |
Why?
|
Carcinoma, Renal Cell | 1 | 2009 | 3181 | 0.110 |
Why?
|
Mice, Knockout | 8 | 2018 | 14448 | 0.110 |
Why?
|
Protein Binding | 2 | 2021 | 9296 | 0.110 |
Why?
|
Brain Chemistry | 3 | 1993 | 952 | 0.110 |
Why?
|
Humans | 54 | 2023 | 765968 | 0.110 |
Why?
|
Cell Membrane Structures | 1 | 2012 | 24 | 0.100 |
Why?
|
Quinazolines | 2 | 2010 | 1364 | 0.100 |
Why?
|
Catenins | 1 | 2012 | 44 | 0.100 |
Why?
|
Kidney Neoplasms | 1 | 2009 | 4274 | 0.100 |
Why?
|
B-Lymphocyte Subsets | 1 | 2013 | 241 | 0.100 |
Why?
|
Neoplasm Proteins | 3 | 2000 | 3596 | 0.100 |
Why?
|
Cell Differentiation | 3 | 2013 | 11641 | 0.100 |
Why?
|
Caco-2 Cells | 1 | 2012 | 366 | 0.100 |
Why?
|
RNA, Small Interfering | 2 | 2015 | 3421 | 0.090 |
Why?
|
Molecular Sequence Data | 14 | 2003 | 17594 | 0.090 |
Why?
|
Centrosome | 1 | 2012 | 209 | 0.090 |
Why?
|
Receptors, Growth Factor | 1 | 2012 | 324 | 0.090 |
Why?
|
Genes, p53 | 4 | 2005 | 711 | 0.090 |
Why?
|
Protein Biosynthesis | 1 | 2018 | 2086 | 0.090 |
Why?
|
Mice, Transgenic | 4 | 2011 | 9550 | 0.090 |
Why?
|
Muscles | 2 | 1993 | 1578 | 0.090 |
Why?
|
Histological Techniques | 1 | 2011 | 193 | 0.090 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2011 | 147 | 0.090 |
Why?
|
alpha Catenin | 1 | 2010 | 37 | 0.090 |
Why?
|
Cell Movement | 2 | 2018 | 5194 | 0.090 |
Why?
|
Stress, Mechanical | 1 | 2015 | 1668 | 0.090 |
Why?
|
Lymphocyte Activation | 2 | 2013 | 5501 | 0.090 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2013 | 545 | 0.090 |
Why?
|
Base Sequence | 13 | 2008 | 12403 | 0.090 |
Why?
|
Research | 2 | 2014 | 1975 | 0.080 |
Why?
|
Muscle Proteins | 2 | 1993 | 1158 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2010 | 2900 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2018 | 2867 | 0.080 |
Why?
|
RNA Interference | 2 | 2015 | 2832 | 0.080 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2011 | 684 | 0.080 |
Why?
|
Immunity, Humoral | 1 | 2013 | 605 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2010 | 3430 | 0.080 |
Why?
|
Alleles | 4 | 2001 | 6897 | 0.080 |
Why?
|
Immunoprecipitation | 1 | 2011 | 870 | 0.080 |
Why?
|
Health Planning Guidelines | 1 | 2009 | 151 | 0.080 |
Why?
|
Muscular Diseases | 1 | 1992 | 550 | 0.070 |
Why?
|
Cold Temperature | 1 | 1992 | 794 | 0.070 |
Why?
|
Immunoblotting | 1 | 2011 | 1644 | 0.070 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2012 | 852 | 0.070 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2008 | 83 | 0.070 |
Why?
|
Ear Neoplasms | 1 | 2008 | 118 | 0.070 |
Why?
|
Cadherins | 1 | 2012 | 900 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1167 | 0.070 |
Why?
|
Cell Compartmentation | 1 | 2007 | 384 | 0.070 |
Why?
|
Drug Design | 1 | 2012 | 1042 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2476 | 0.070 |
Why?
|
Ceramides | 1 | 2008 | 201 | 0.070 |
Why?
|
DNA | 6 | 1993 | 7202 | 0.070 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2011 | 752 | 0.060 |
Why?
|
Keratinocytes | 1 | 2010 | 863 | 0.060 |
Why?
|
Nerve Tissue Proteins | 3 | 2001 | 4392 | 0.060 |
Why?
|
Solubility | 1 | 2007 | 1078 | 0.060 |
Why?
|
RNA Splicing | 1 | 1990 | 903 | 0.060 |
Why?
|
Chromosome Deletion | 1 | 1990 | 1385 | 0.060 |
Why?
|
Mutant Proteins | 1 | 2007 | 488 | 0.060 |
Why?
|
Peripheral Nervous System | 1 | 2007 | 151 | 0.060 |
Why?
|
Thymus Gland | 1 | 2010 | 1261 | 0.060 |
Why?
|
Skin Neoplasms | 3 | 2014 | 5849 | 0.060 |
Why?
|
Pigment Epithelium of Eye | 1 | 2005 | 209 | 0.060 |
Why?
|
Amino Acid Sequence | 6 | 2001 | 13400 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2014 | 17075 | 0.060 |
Why?
|
Stem Cell Niche | 1 | 2008 | 346 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2020 | 3607 | 0.060 |
Why?
|
Cholangiocarcinoma | 1 | 2010 | 578 | 0.060 |
Why?
|
Cell Cycle | 1 | 2012 | 2920 | 0.060 |
Why?
|
3T3 Cells | 3 | 2001 | 1081 | 0.060 |
Why?
|
Microscopy, Electron | 2 | 2005 | 2548 | 0.060 |
Why?
|
Cell Line | 4 | 2020 | 15543 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2012 | 9249 | 0.060 |
Why?
|
Cochlear Implantation | 1 | 2008 | 317 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2010 | 2329 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 2 | 2010 | 3737 | 0.050 |
Why?
|
rap GTP-Binding Proteins | 1 | 2003 | 24 | 0.050 |
Why?
|
Endocytosis | 1 | 2007 | 951 | 0.050 |
Why?
|
Consensus | 2 | 2011 | 3202 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2003 | 6113 | 0.050 |
Why?
|
Acute-Phase Proteins | 1 | 2004 | 252 | 0.050 |
Why?
|
Heterozygote | 2 | 2001 | 2794 | 0.050 |
Why?
|
Polymorphism, Genetic | 5 | 1992 | 4247 | 0.050 |
Why?
|
Hepatocyte Growth Factor | 1 | 2004 | 268 | 0.050 |
Why?
|
Structure-Activity Relationship | 1 | 2007 | 3051 | 0.050 |
Why?
|
Animals, Newborn | 2 | 2005 | 2669 | 0.050 |
Why?
|
Phosphorylation | 4 | 2013 | 8278 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2011 | 11022 | 0.050 |
Why?
|
rho GTP-Binding Proteins | 1 | 2003 | 280 | 0.050 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2008 | 781 | 0.050 |
Why?
|
Genes, Regulator | 1 | 2003 | 373 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2010 | 3513 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 3 | 2014 | 5696 | 0.050 |
Why?
|
Eukaryotic Cells | 1 | 2003 | 192 | 0.050 |
Why?
|
Clinical Trials as Topic | 4 | 2014 | 8041 | 0.050 |
Why?
|
Piperidines | 1 | 2010 | 1664 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2011 | 8611 | 0.050 |
Why?
|
Exons | 3 | 1992 | 2391 | 0.050 |
Why?
|
Models, Biological | 2 | 2007 | 9443 | 0.050 |
Why?
|
Pedigree | 4 | 1992 | 4526 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2009 | 1811 | 0.040 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2001 | 187 | 0.040 |
Why?
|
Down-Regulation | 1 | 2007 | 2927 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3750 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4778 | 0.040 |
Why?
|
Cell Lineage | 1 | 2009 | 2573 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2056 | 0.040 |
Why?
|
Mammals | 1 | 2005 | 1125 | 0.040 |
Why?
|
Models, Animal | 2 | 2004 | 2120 | 0.040 |
Why?
|
Cyclin D | 2 | 2011 | 70 | 0.040 |
Why?
|
Leukemia | 1 | 2008 | 1522 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2007 | 1889 | 0.040 |
Why?
|
Biomimetics | 1 | 2020 | 168 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2012 | 3946 | 0.040 |
Why?
|
Hybrid Cells | 3 | 1993 | 421 | 0.040 |
Why?
|
Phenotype | 4 | 2020 | 16721 | 0.040 |
Why?
|
Cloning, Molecular | 3 | 1993 | 4165 | 0.040 |
Why?
|
Cell Division | 2 | 2004 | 4475 | 0.040 |
Why?
|
RNA, Messenger | 2 | 1990 | 12768 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2013 | 22332 | 0.040 |
Why?
|
Cell Survival | 2 | 2008 | 5747 | 0.040 |
Why?
|
Sequence Alignment | 2 | 1992 | 2171 | 0.040 |
Why?
|
Gene Targeting | 2 | 2000 | 841 | 0.040 |
Why?
|
Fibroblasts | 1 | 2007 | 4159 | 0.030 |
Why?
|
Apoptosis | 4 | 2014 | 9514 | 0.030 |
Why?
|
Homozygote | 2 | 2003 | 1775 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2002 | 933 | 0.030 |
Why?
|
Fetus | 1 | 2004 | 1870 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2008 | 3401 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 904 | 0.030 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 1991 | 766 | 0.030 |
Why?
|
Huntington Disease | 2 | 1992 | 1147 | 0.030 |
Why?
|
DNA Mutational Analysis | 3 | 2008 | 4108 | 0.030 |
Why?
|
Gene Expression | 4 | 2001 | 7584 | 0.030 |
Why?
|
Meningioma | 3 | 2011 | 1221 | 0.030 |
Why?
|
Genetic Linkage | 2 | 1992 | 2341 | 0.030 |
Why?
|
Mutagenesis | 1 | 1998 | 1228 | 0.030 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2014 | 146 | 0.030 |
Why?
|
Antineoplastic Agents | 3 | 2014 | 13648 | 0.030 |
Why?
|
Chromosome Mapping | 2 | 1992 | 4618 | 0.030 |
Why?
|
Gamma Rays | 1 | 1994 | 324 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2010 | 10261 | 0.030 |
Why?
|
Polymerase Chain Reaction | 5 | 1992 | 6069 | 0.030 |
Why?
|
Fibrosarcoma | 1 | 1994 | 313 | 0.030 |
Why?
|
Transfection | 3 | 2014 | 5743 | 0.030 |
Why?
|
Amyloid | 2 | 1988 | 853 | 0.030 |
Why?
|
Sequence Tagged Sites | 1 | 1992 | 96 | 0.020 |
Why?
|
Oocytes | 2 | 1993 | 1169 | 0.020 |
Why?
|
Xenopus | 1 | 1993 | 709 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1992 | 416 | 0.020 |
Why?
|
G2 Phase | 1 | 2011 | 135 | 0.020 |
Why?
|
Mice, Nude | 3 | 2010 | 3618 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4260 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 2003 | 1056 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2011 | 2056 | 0.020 |
Why?
|
Chromosomes, Human | 1 | 1992 | 437 | 0.020 |
Why?
|
Hemoglobinopathies | 1 | 1990 | 101 | 0.020 |
Why?
|
S Phase | 1 | 2011 | 424 | 0.020 |
Why?
|
Hyperkalemia | 1 | 1992 | 233 | 0.020 |
Why?
|
Auditory Brain Stem Implants | 1 | 2009 | 33 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13451 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2020 | 2593 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2014 | 811 | 0.020 |
Why?
|
Sequence Deletion | 2 | 2008 | 1495 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2010 | 381 | 0.020 |
Why?
|
Forecasting | 1 | 1998 | 2936 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2011 | 591 | 0.020 |
Why?
|
Immunological Synapses | 1 | 2009 | 57 | 0.020 |
Why?
|
Kinetics | 2 | 1993 | 6274 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2010 | 9071 | 0.020 |
Why?
|
Mice, Mutant Strains | 2 | 2003 | 1745 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2020 | 4427 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1885 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2008 | 351 | 0.020 |
Why?
|
Pyridoxine | 1 | 1988 | 108 | 0.020 |
Why?
|
Doxorubicin | 1 | 1994 | 2230 | 0.020 |
Why?
|
Genetic Techniques | 1 | 1990 | 429 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2004 | 9525 | 0.020 |
Why?
|
Rats | 3 | 2011 | 23707 | 0.020 |
Why?
|
Audiometry, Pure-Tone | 1 | 2008 | 210 | 0.020 |
Why?
|
Transaminases | 1 | 1988 | 199 | 0.020 |
Why?
|
Standard of Care | 1 | 2011 | 567 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2009 | 737 | 0.020 |
Why?
|
Point Mutation | 1 | 1992 | 1590 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1740 | 0.020 |
Why?
|
Auditory Threshold | 1 | 2008 | 369 | 0.020 |
Why?
|
Up-Regulation | 2 | 2010 | 4137 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 1823 | 0.020 |
Why?
|
Meningeal Neoplasms | 2 | 2009 | 1252 | 0.020 |
Why?
|
Telomere | 1 | 1992 | 943 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1352 | 0.020 |
Why?
|
Asbestos, Crocidolite | 1 | 2005 | 18 | 0.020 |
Why?
|
Cocarcinogenesis | 1 | 2005 | 49 | 0.020 |
Why?
|
Female | 6 | 2020 | 396112 | 0.020 |
Why?
|
Haplotypes | 1 | 1992 | 2728 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3608 | 0.020 |
Why?
|
Male | 7 | 2010 | 363698 | 0.020 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2005 | 84 | 0.020 |
Why?
|
Time Factors | 3 | 2014 | 40065 | 0.020 |
Why?
|
Vestibular Diseases | 1 | 2008 | 230 | 0.020 |
Why?
|
Cyclins | 1 | 2007 | 598 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2007 | 545 | 0.020 |
Why?
|
Stromal Cells | 1 | 2010 | 1329 | 0.010 |
Why?
|
Cochlear Implants | 1 | 2009 | 342 | 0.010 |
Why?
|
Photoreceptor Cells | 1 | 2005 | 234 | 0.010 |
Why?
|
Macromolecular Substances | 2 | 2000 | 1430 | 0.010 |
Why?
|
Spleen | 1 | 2010 | 2296 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 1988 | 746 | 0.010 |
Why?
|
Gene Expression Regulation | 3 | 2007 | 11888 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2009 | 1333 | 0.010 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2007 | 618 | 0.010 |
Why?
|
Retinal Degeneration | 1 | 1988 | 413 | 0.010 |
Why?
|
Protein Precursors | 1 | 1988 | 1134 | 0.010 |
Why?
|
Prevalence | 1 | 2001 | 15842 | 0.010 |
Why?
|
Genes | 1 | 1987 | 1825 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1993 | 6493 | 0.010 |
Why?
|
Metabolic Networks and Pathways | 1 | 2008 | 798 | 0.010 |
Why?
|
Osteoblasts | 1 | 2008 | 1143 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2822 | 0.010 |
Why?
|
Radiosurgery | 1 | 2011 | 1328 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10729 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2011 | 2589 | 0.010 |
Why?
|
Models, Molecular | 1 | 1992 | 5379 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2010 | 2058 | 0.010 |
Why?
|
Cytoplasm | 1 | 2005 | 1500 | 0.010 |
Why?
|
Protein Kinases | 1 | 2007 | 1611 | 0.010 |
Why?
|
Sirolimus | 1 | 2007 | 1545 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1992 | 705 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 2631 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2009 | 2570 | 0.010 |
Why?
|
Genes, Insect | 1 | 2000 | 265 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2000 | 348 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2007 | 2453 | 0.010 |
Why?
|
Insect Proteins | 1 | 2000 | 253 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 1560 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2003 | 2745 | 0.010 |
Why?
|
Drug Resistance | 2 | 1994 | 1591 | 0.010 |
Why?
|
Hamartoma | 1 | 2000 | 233 | 0.010 |
Why?
|
Threonine | 1 | 1998 | 272 | 0.010 |
Why?
|
G1 Phase | 1 | 1998 | 403 | 0.010 |
Why?
|
Mosaicism | 1 | 2000 | 481 | 0.010 |
Why?
|
Neuroma, Acoustic | 1 | 2000 | 456 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8529 | 0.010 |
Why?
|
Alzheimer Disease | 2 | 1988 | 8730 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 6209 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2000 | 1718 | 0.010 |
Why?
|
Gene Frequency | 2 | 1992 | 3624 | 0.010 |
Why?
|
Goals | 1 | 2000 | 719 | 0.010 |
Why?
|
Serine | 1 | 1998 | 824 | 0.010 |
Why?
|
Cataract | 1 | 2000 | 837 | 0.010 |
Why?
|
Retinal Diseases | 1 | 2000 | 709 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 2000 | 708 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2003 | 1477 | 0.010 |
Why?
|
RNA, Complementary | 1 | 1993 | 46 | 0.010 |
Why?
|
Age of Onset | 1 | 2000 | 3344 | 0.010 |
Why?
|
Metaphase | 1 | 1992 | 144 | 0.010 |
Why?
|
Cell Death | 1 | 1998 | 1679 | 0.010 |
Why?
|
Chromosomes, Fungal | 1 | 1992 | 110 | 0.010 |
Why?
|
Radiation Tolerance | 1 | 1994 | 475 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2008 | 3646 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1992 | 848 | 0.010 |
Why?
|
HeLa Cells | 1 | 1998 | 3067 | 0.010 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1991 | 167 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2000 | 1721 | 0.010 |
Why?
|
RNA Probes | 1 | 1990 | 110 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1991 | 772 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1994 | 2014 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2003 | 2567 | 0.010 |
Why?
|
DNA Probes | 1 | 1991 | 541 | 0.010 |
Why?
|
Ribonuclease, Pancreatic | 1 | 1990 | 112 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2008 | 5753 | 0.010 |
Why?
|
Adult | 3 | 2000 | 223044 | 0.010 |
Why?
|
Globins | 1 | 1990 | 406 | 0.010 |
Why?
|
Membrane Potentials | 1 | 1993 | 1083 | 0.010 |
Why?
|
Gene Library | 1 | 1992 | 1067 | 0.010 |
Why?
|
DNA, Single-Stranded | 1 | 1991 | 353 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 1994 | 866 | 0.000 |
Why?
|
Genetic Counseling | 1 | 1992 | 634 | 0.000 |
Why?
|
In Situ Hybridization | 1 | 1992 | 1886 | 0.000 |
Why?
|
Carrier Proteins | 1 | 2000 | 4913 | 0.000 |
Why?
|
Serine Proteinase Inhibitors | 1 | 1988 | 173 | 0.000 |
Why?
|
Genetic Markers | 1 | 1992 | 2601 | 0.000 |
Why?
|
Nucleic Acid Hybridization | 1 | 1988 | 1306 | 0.000 |
Why?
|
Genotype | 1 | 2000 | 13024 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 18071 | 0.000 |
Why?
|
RNA | 1 | 1993 | 2717 | 0.000 |
Why?
|
Disease Progression | 1 | 2000 | 13632 | 0.000 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 1988 | 1116 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2008 | 65188 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36532 | 0.000 |
Why?
|
Down Syndrome | 1 | 1988 | 915 | 0.000 |
Why?
|
Genome, Human | 1 | 1992 | 4448 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1992 | 14652 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1994 | 9373 | 0.000 |
Why?
|
Amyloid beta-Peptides | 1 | 1987 | 3896 | 0.000 |
Why?
|
Middle Aged | 1 | 2008 | 223009 | 0.000 |
Why?
|
Prognosis | 1 | 1994 | 29922 | 0.000 |
Why?
|
Brain | 1 | 1988 | 27171 | 0.000 |
Why?
|